Toronto and Vancouver, Canada: Zucara Therapeutics Inc., a diabetes life sciences company advancing the first once-daily therapeutic to prevent low blood glucose levels (hypoglycemia), has secured US$3.9 million in non-dilutive funding […]
VANCOUVER and TORONTO, Canada — Zucara Therapeutics Inc., a pre-clinical life sciences company advancing a novel long-term therapeutic approach to prevent hypoglycemia in patients with diabetes, has received support of […]
Michael Midmer, CEO of Zucara Therapeutics, is confirmed to present at the 10th Annual Biotech Showcase. This important investor and networking conference is a great opportunity for Zucara to showcase […]
NEW YORK, USA and TORONTO, Canada, September 21, 2017 — As Global Biotech Week begins in more than 20 countries, JDRF, the leading organization funding type 1 diabetes (T1D) research, […]
VANCOUVER and TORONTO, Canada — Zucara Therapeutics Inc., a pre-clinical life sciences company advancing a novel long-term therapeutic approach to prevent hypoglycemia in patients with diabetes, is pleased to announce […]
VANCOUVER and TORONTO, Canada (July 10, 2017) — Zucara Therapeutics Inc., a pre-clinical life sciences company advancing a novel long-term therapeutic approach to prevent hypoglycemia in patients with diabetes, is […]
On March 3, 2017 Rocket Builders announced its 15th annual “Ready to Rocket” lists. These lists profile British Columbia technology companies that are best positioned to capitalize on the technology sector trends […]
New paper published in The Lancet Diabetes & Endocrinology recommends exercise guidelines for type 1 diabetes patients and healthcare providers. Experts from JDRF, the leading global organization focused on type […]
For Immediate Release BC Ministry of Health Diabetes Awareness Month: diabetes research VICTORIA – Health Minister Terry Lake has issued the following statement for Diabetes Awareness Month: “Diabetes affects over 400,000 […]
Zucara announced it has received a $525,000 investment from Canadian partners: Accel-Rx Health Sciences Accelerator, The Centre for Drug Research and Development (CDRD) and MaRS Innovation (MI). VANCOUVER and TORONTO, […]